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ABSTRACT
Determination of the in vivo binding sites of RNA-
binding proteins (RBPs) is paramount to understand-
ing their function and how they affect different as-
pects of gene regulation. With hundreds of RNA-
binding proteins identified in human cells, a flexible,
high-resolution, high-throughput, highly multiplexi-
ble and radioactivity-free method to determine their
binding sites has not been described to date. Here
we report FLASH (Fast Ligation of RNA after some
sort of Affinity Purification for High-throughput Se-
quencing), which uses a special adapter design and
an optimized protocol to determine protein–RNA in-
teractions in living cells. The entire FLASH protocol,
starting from cells on plates to a sequencing library,
takes 1.5 days. We demonstrate the flexibility, speed
and versatility of FLASH by using it to determine RNA
targets of both tagged and endogenously expressed
proteins under diverse conditions in vivo.
INTRODUCTION
In eukaryotic organisms, RNA polymerase II is respon-
sible for the transcription of all mRNAs that serve as
templates for protein synthesis in the cytoplasm. Several
highly regulated RNA-processing events are required to
produce translation-competent mRNAs and guide their
passage from the nucleus to the cytoplasm. These events
are almost exclusively carried out by RNA-binding proteins
(RBPs) that recognize short sequence motifs, specific RNA
structures and/or RNA modifications (1,2). Understand-
ing how the collective action of RBPs determines the fate
of mRNAs requires the accurate and precise identification
of their cellular targets. Current protocols that are up to
this challenge are generally called CLIP-seq (crosslinking
and immunoprecipitation) approaches, where either UV-
C light (wavelength ∼254 nm) or UV-A light (wavelength
∼365 nm, in combination with a photoactivatable ribonu-
cleotide analogue incorporated into target RNAs) is used
to directly induce protein-RNA crosslinks, then the result-
ing RNA–protein adducts are purified, proteins are typi-
cally removed by Proteinase K treatment and the RNA is
cloned into a sequencing library, sequenced and finally an-
alyzed. Many state-of-the-art CLIP-seq methods are, how-
ever, notoriously difficult as they require use of radioactive
substances and isolation of minute amounts of RNA from
nitrocellulose paper (3). Due to these design choices, and
other technical challenges, these protocols take several days
to complete, and are typically restricted to one or two pro-
teins per iteration. Recently developed techniques address
some of these problems by bypassing radioactive labeling
and/or isolation of RNA from nitrocellulose paper or acry-
lamide gels (4–6). Here, we report a new protocol, FLASH,
that surpasses these techniques in terms of flexibility, multi-
plexibility and speed, while retaining single-nucleotide res-
olution and specificity owing to a new adapter design.
Since it is not immediately obvious how a change in
adapter design can lead to dramatic improvements in the
protocol, we first detail the design elements of this new
adapter, followed by the description of how these elements
come together to solve several technical challenges in CLIP
or CLIP-like experiments that require ligation-mediated
cloning ofRNA. In order to test the performance and appli-
cability of FLASH in various experimental scenarios, we re-
port FLASHprofiles of several important RBPswith differ-
ent cellular roles (Figure 1A), beginning with the optimiza-
tion of the FLASH protocol using two isoforms of the KH-
type RBPQKI, QKI-5 andQKI-6 (Figure 2). QKI is a well-
studiedRBPwith roles in splicing, circularRNA formation,
RNA stability and translation (7). QKI is able to influence
both nuclear and cytoplasmic events since the endogenous
gene produces protein variants through alternative splicing
that localize to the nucleus, cytoplasm or both compart-
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Figure 1. (A) A typical multi-exonic mammalian transcript depicted together with a plethora of RNA binding proteins. (B) Schematic description of the
s-oligo. See text for details. (C) A ‘Blueprint’ of FLASH protocols, depicting various experimental alternatives. (D) Step-wise explanation of the enzymatic
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Figure 2. (A) Schematic representation of all the conditions that were tested with QKI-5 and QKI-6. For a more complete description see Supplementary
Figures S1 and S2. (B) Signal-to-noise ratios of the XF libraries, higher ratios are indicative of lower background. (C) Frequency distribution of crosslinked
nucleotides in the vicinity of the QKImotif AYUAA inXF libraries. (D) An Integrative Genomics Viewer (IGV) screenshot of QKI FLASHdata compared
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ments (8). Furthermore, cellular RNA targets of QKI have
been described before, including its preferred sequence mo-
tif, and preferred target classes for both isoforms, making it
possible to directly assess the performance of different pro-
tocol variations (6,9–10). With the optimal conditions es-
tablished, we then report FLASH profiles of U2AF65 (Fig-
ure 3), an RRM-type RBP that recognizes polypyrimidine
tracts and which together with U2AF35 is instrumental in
defining splice-acceptor sites. Another important class of
RBPs that are critical for splicing are the serine/arginine
(SR)-rich proteins, which play important roles in exon defi-
nition as well as nuclear export of mRNAs (11). We report
FLASH profiles of nine SR proteins and a clinically impor-
tant point mutant of SRSF2 (Figure 4). Finally, to exploit
and demonstrate the speed and flexibility of FLASH, we
profile transiently transfected QKI constructs in a 6-well
plate format, and assess the practicality and utility of such
a setup (Figure 5).
MATERIALS AND METHODS
Cell culture and generation of stable cell lines
Flp-In T-REx 293 (Thermo Fisher Scientific, R78007) cells
were maintained with DMEM-Glutamax supplemented
with sodium pyruvate, glucose and 10% FBS. In addition to
those supplements, Flp-In T-REx 293 cells were maintained
in zeocin (Thermo Fisher Scientific, R25001)- and blas-
ticidin (Thermo Fisher Scientific, A1113903) -containing
medium according to manufacturer’s protocol and the
zeocin selection is exchanged with hygromycin (Thermo
Fisher Scientific, 10687010) upon transgene transfection.
All the transgenes were cloned into pCDNA5-FRT/TO
(Thermo Fisher Scientific, V6520-20) with a C-terminal
3× Flag–HBH tag by PCR amplification of the coding
sequence from cDNA prepared from Flp-In T-REx 293
cells with the oligos listed in Supplementary Table S1.
U2AF65 was ordered from the BIOSS Toolbox, Univer-
sity of Freiburg, and originally is from human ORFeome
V5.1 collection (Open Biosystems) with ID:4551. Trans-
genes were co-transfected with pOG44 (Thermo Fisher Sci-
entific, V600520) plasmidwith a 1:9DNAconcentration ra-
tio for the generation of stable cell lines. Cells were re-plated
in different dilutions (in order to assure the impact of cell
density on cell survival after antibiotics selection) 24 h after
transfection and 150 g per ml hygromycin selection was
initiated 48 h after transfection. Cell lines were maintained
with blasticidin and hygromycin at all times and the trans-
genes were induced over-night with 0.1 g per ml doxycy-
cline.
Transfection and induction for transient FLASH
A total of 800 000 Flp-In T-REx 293 cells were transfected
with 1 g of plasmid DNA (pCDNA5-FRT/To plasmid
carrying the tagged gene) in a 6-well plate. The medium was
exchanged 6 h after the transfectionwith amedium carrying
0.1 g per ml doxycycline.
s-oligo
The adapters used in FLASHprotocols, the s-oligo were or-
dered from Integrated DNATechnologies (IDT). The com-
plete list of s-oligos used in this study can be found in Sup-
plementary Table S1. We use one example to explain the





rN: ribonucleotide (random in this case)
/iSp18/: 8-atom hexa-ethyleneglycol spacer
/3Phos/: 3′phosphate group
A, G, T or C: DNA moieties
FLASH protocols
The XF2 flavor of the protocol, described below, is de-
posited to protocols.io as a step-by-step protocol: https://
www.protocols.io/view/flash-zv9f696?version warning=no
For most FLASH protocols, cells grown in 15-cm dishes
and are induced with 0.1 g/ml doxycycline for ∼16 h.
Medium is removed, cells are washed once with 6 ml of ice-
cold PBS, then 6ml of fresh ice cold PBS is carefully layered
on top of the cells and cells are crosslinked on an ice-water
tray with 0.15 mJ/cm2 UV-C light. The cells are collected
into a 15-ml Falcon tube with the help of a cell scraper, spun
down in a cold centrifuge at 500g, washed once with 1 ml
ice-cold PBS, re-pelleted at 500g and snap-frozen in liquid
nitrogen until use. On the day of the experiment, the cells
are allowed to thaw on ice for∼2 min and resuspended with
550 l of NLB (1× PBS, 0.3 M NaCl, 1% Triton-X, 0.1%
Tween-20). The lysate is then sonicated with a Bioruptor
sonifier (Diagenode) for 5 mins (30 s ON, 30 s OFF, LOW,
5 cycles at 4◦C). Insoluble material is removed by centrifu-
gation at 20 000g for 10 min at 4◦C.
QKI protocols (XF1, XF2, XF3 and XF4). The clarified
lysate in NLB is incubated for 5 min (maximum 10 min)
with 25 l of Dynabeads™His-Tag Isolation and Pulldown
beads (catalogue number: 10103D, Thermo Fisher Scien-
tific), which are washed once with NLB and resuspended in
500 l NLB. After the incubation, the beads are collected
with a magnet, supernatant is removed, and the beads are
washed with 800 l of NLB. Elution is carried out with
NLB supplemented with 250 mM imidazole, for 10 min
on ice. The eluate is then incubated with 25 l of Dyn-
abeads™ MyOne™ Streptavidin C1 beads (catalogue num-
ber: 65002, Thermo Fisher Scientific), which are washed
once with NLB and resuspended in 500 l NLB and in-
cubated in the cold-room (∼4◦C) for 1 h. The supernatant
is removed, and the beads are washed with LDS buffer (20
mMTris-Cl pH 7.4, 0.5MLiCl, 1 mMEDTA, 0.5% LiDS),
PLB (20 mM Tris-Cl pH 7.4, 0.5 M LiCl, 1 mM EDTA,
1% SDS), HSB (50 mM Tris-Cl pH 7.4, 1 M NaCl, 1%
IGEPAL CA-630, 0.1% SDS, 1 mM EDTA) and NDB (50
mM Tris-Cl pH 7.4, 100 mM NaCl, 0.1% Tween-20). The
beads are then resuspended with 1 ml of NDB, to which
2 l of TURBO DNAse (AM2238, Thermo Fisher Scien-
tific) and 10 l of diluted RNaseI (1:2000 dilution in NDB,
AM2294, Thermo Fisher Scientific) is added and incubated
at 37◦C for 3 min. The lysates are cooled on ice for 2 min,
before removal of the supernatant. Beads are then washed
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Figure 3. (A) The experimental design to compare FLASHendo (i.e. with antibody) and FLASHtagged protocols for U2AF65. (B) Bioanalyzer traces of the
sequencing libraries generated using antibodies against endogenously expressedU2AF65 (lanes 2 and 3) and using a cell line that expresses taggedU2AF65
(lanes 4 and 5). (C) Positioning of U2AF65 binding events with respect to the intron-exon boundaries where U2AF65 typically binds to the polypyrimidine
tract. (D) Distribution of the U2AF65 sequence motif as calculated by GraphProt on PEAKachu peaks determined from alignments (‘alns’, top lane) and
crosslinked nucleotides (‘clnts’, bottom lane). WCE: Whole cell extract. (E) An IGV screenshot of U2AF65 FLASH data in comparison to eCLIP data
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Figure 4. (A) The common FLASH protocol that was used to generate SR-FLASH data. (B) Schematic representation of the domain architecture of SR
proteins used in this work. (C) An immunoblot showing the levels of purified proteins used for FLASH. (D) Bioanalyzer quantification of SR sequencing
libraries. (E) A correlation plot for all the SR libraries and the internal GFP controls. (F) Extracted motifs and their structure for all the SR proteins. See
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Figure 5. (A) Description of the transient FLASH protocol used for QKI-5 and QKI-6, with GFP as a negative control. (B) Bioanalyzer quantification










enetik user on 15 January 2020
8 Nucleic Acids Research, 2019
tion of the 3′-cyclic phosphate is carried out at 37◦C for 20
min in a 20 l reaction that contains 10 l of 2× PNK-
MES buffer (50 mM MES pH 6.0, 100 mM NaCl, 10 mM
MgCl2, 0.1% Tween-20), 0.5 l RNasin (N2511, Promega),
1 l of -mercaptoethanol (0.1 M), 1 l of T4 PNK (10
U/l, M0201, NEB) and 7.5 l of water. After the PNK-
reaction, the beads are washed once with HSB and twice
withNDB. Each sample is then ligatedwith a unique s-oligo
at 25◦C for 1 h, in a reaction mixture that contains 2 l of
10× T4 RNA Ligase Buffer, 4 l of PEG8000, 1 l of s-
oligo (10 M), 2 l of ATP (1 mM), 0.5 l of RNasin Plus
(40 U/l), 1 l T4 RNA Ligase 1 (M0204L, NEB) and 9.5
l of water. The beads are thenwashed oncewithHSB, once
with NDB. At this stage relevant samples are mixed as they
are now uniquely tagged. The 3′-phosphate group of the s-
oligo is removed with T4 PNK, with the reaction setup de-
scribed above, after which the beads are washed once with
HSB and once with NDB.
For XF1 and XF2. The beads are resuspended with 100 l
of Proteinase Kmix (100 mMTris-Cl pH 7.4, 50 mMNaCl,
0.1% Tween-20, 10 mM EDTA, 0.1%SDS, 10 l Proteinase
K [20 mg/ml 25530049, Thermo Fisher Scientific]), and in-
cubated at 37◦C to digest all proteins and release the RNA
into solution. The RNA is then purified using the Oligo
Clean & Concentrator kit (Zymo Research, D4060) with
200 l of binding buffer and 400 l of ethanol for binding
to the column and 9.5 l of water for elution. The eluted
RNA is reverse-transcribed at 42◦C for 10 min, 50◦C for 10
min and 55◦C for another 10 min with SuperScript III in a
reaction mixture that contains 2 l of 10× Buffer, 1 l of
10mM dNTPs, 4 l of 25 mM MgCl2, 2 l of 0.1 M DTT,
1 l of RNaseOUT, 1 l of SuperScript III and 9 l of the
RNA eluate.
For XF1. About 2.5 l of 1 M NaOH is added to the
reverse-transcription reaction which is then incubated at
70◦C for 10 min. The reaction is then neutralized with the
addition of 2.5l of 1MHCl. To the neutralized and cooled
reaction mixture, 47.5 l of 10 mM Tris-Cl (pH 7.4), 0.75
l of ATP (0.1 M), 0.75 l of -mercaptoethanol (0.1 M)
and 1 l of T4 PNK is added and the tubes are incubated
at 37◦C for 15 min to phosphorylate the 5′-ends of cDNA
molecules, which is necessary for circularization. The phos-
phorylated cDNA is then purified with Oligo Clean & Con-
centrator kit with 150 l of binding buffer and 300 l of
ethanol for binding to the column. About 6.5 l of water
was used for the elution.
For XF2. About 1 l of RNaseH is added to the reverse-
transcription reaction and incubate at 37◦C for 20 min.
About 54 l of water is added to the reaction to bring the
volume to 75 l, after which the phosphorylated cDNA is
purified with Oligo Clean & Concentrator kit with 150 l
of binding buffer and 300 l of ethanol for binding to the
column. About 6.5 l of water was used for elution.
For XF3 andXF4. Directly after ligation of the s-oligo and
appropriate mixing of samples, the beads are resuspended
with the following reverse-transcription mixture: 4 l of
5× Buffer, 1 l MonsterScript, About 15 l of water, and
incubated at 42◦C for 5 min, then at 60◦C for 15 min, at
70◦C for 5 min and finally at 75◦C for 5 min.
For XF3. NaOH and T4 PNK treatment, same as XF1.
For XF4. RnaseH treatment, same as XF2.
5′-phosphorylated cDNA fromXF1, XF2, XF3 andXF4
are circularised using CircLigaseII (Lucigen, CL9021K) in
a 10l reaction consisting of 1l of 10×Buffer, 0.5l of 50
mMMnCl2, 2 l of 5MBetaine, 0.5 l of CircLigaseII and
6 l of eluted 5′-phosphorylated cDNA. The reactions are
carried out at 60◦C in a hybridization oven (air-incubator)
for ∼16 h. The circularization reaction is then used, with-
out purification, in a PCR reaction: 20 l of 2× NEBNext
Q5 Master Mix, 1 l of P5 primer (10 M, universal), 1
l of P3 primer (10 M, barcoded), 9 l of cDNA, 8 l
of water. The cycle number is either guessed based on ex-
perience or determined using a qPCR reaction where 1 l
of circularized is cDNA used and the Ct value is used as
the final cycling number with the NEBNext enzyme (NEB,
M0541S). Final PCR reaction is cleaned up with 1.5×AM-
Pure beads (Agencourt, A63881), twice to completely re-
move leftover primers and eluted with 10mM Tris.Cl (pH
8) supplemented with 0.1% Tween-20. Sequencing libraries
are quantified with Qubit DNA HS assay (Thermo Fisher
Scientific, Q32851) and with a Bioanalyzer High Sensitiv-
ity DNA chip (Agilent, 5067–4626) and submitted for high-
throughput sequencing to the Deep Sequencing Facility at
the Max Planck Institute of Immunobiology and Epigenet-
ics.
XF5, XF6, XF7 and XF8. The clarified lysate is incu-
bated for 60 min with 25 l Dynabeads™ Protein G beads
(10003D, Thermo Fisher Scientific), coupled to 1 l of
FLAG-M2 mAb (Sigma, F1804) then washed once with
NLB. The beads are then resuspended with 1 ml of NDB
and the protocols described for XF1-4 above are followed
exactly, in that XF5 ∼ XF1, XF6 ∼ XF2, XF7 ∼XF3 and
XF8 ∼ XF4. For an overview of these protocols see Figure
2, Supplementary Figures S1 and S2.
U2AF65 protocols (XL17, XL18, XL21, XL22). For
XL17 and XL18 the XF6 protocol was followed with the
following modifications: the FLAGmAb was replaced with
a monoclonal antibody against U2AF65 (Sigma U4758,
∼1 mg/ml, 5 l of mAb coupled to 25 l of Dynabeads™
Protein G beads), for XL17 the RNaseI was diluted 1:500
in NDB, for XL18, RNaseI dilution was kept at 1:2000.
ForXL21 andXL22, theXF2 protocol was followedwith
an RNaseI dilution of 1:1000, using a stable cells that ex-
presses U2AF653xFHBH. Additionally, for the XL21 library,
nuclei was isolated first by incubating the cells on ice for 10
min with HLB (10 mMHEPES.Cl pH 7.9, 1.5 mMMgCl2,
10 mM KCl), after which the IGEPAL CA-630 was added
to 0.5% (final) and the cells were left on ice for 5 min. The
nuclei are then pelleted by centrifugation at 500g for 2 min,
washed with HLB once, and re-suspended with 500 l NLB
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SR protocols. XF2 protocol was followed with an RNaseI
dilution of 1:2000 using cell lines that express SR proteins
tagged with the 3xFHBH tag.
Also see Supplementary Table S1 for FLASH s-oligo se-
quences used for libraries reported in this study.
Antibodies
U2AF65 (monoclonal mouse antibody Sigma U4758),
Flag-HRP (Sigma A8592), FLAG-M2 mAb (Sigma,
F1804).
Bioinformatics
FLASH read processing and mapping was performed
using the Galaxy platform (12). Adapters were trimmed
using Flexbar (v2.5) (13). Libraries were demultiplexed
using bctools (https://github.com/dmaticzka/bctools,
v0.2.0) and Flexbar (v2.5). Custom FLASH adapters
contained two barcodes and random nucleotides ad-
jacent to the 3′-adapters according to the pattern
NNB1B2NT1T2T3T4T5T6NN (N = random tag nu-
cleotide; T = tag nucleotide; B = RY-space tag nucleotide).
Random tags were used to merge PCR duplicates, regular
tags were used to specify the pull-down condition. The
semi-random RY-space tags were used to distinguish the
biological replicates of libraries XF1-XF8. The remaining
libraries employ regular tags to distinguish both pull-down
condition and biological replicates. Possible readthroughs
into the barcoded regions were removed by clipping 13 nt
from the 3′ ends of first mate reads. Reads were mapped
to reference genome hg19 using bowtie2 (v2.2.6) (14)
with parameters: –very-sensitive –end-to-end –no-mixed
–no-discordant –maxins 500. We excluded all reads for
which bowtie2 could identify multiple distinct alignments
as indicated by the XS:i flag and used the alignments
of the remaining uniquely mapped reads to determine
crosslinking events as previously described (15).
Peaks used for motif detection were called using Pure-
CLIP (v1.0.4) (16).
Binding motifs (Figures 4F and 5C, Supplementary Fig-
ures S1 and S9 were created using GraphProt (v1.1.7) (17).
Unbound sequences used for training were selected by ran-
domly placing peaks within genes with at least one binding
site and at least 100 nucleotides apart from any bound site.
GraphProt sequence models were trained based on the 60
nucleotides surrounding peak centers. GraphProt sequence-
and-structure models additionally used 150 nucleotides up-
and downstream to calculate RNA secondary structures.
GraphProt parameters were optimized using 200 bound
and unbound sites. Motifs were generated based on the
20% highest-scoring sequences among the bound training
instances.
Peaks used for the analysis shown in Figure 3D were
called using PEAKachu (version 0.1.0, parameters: –
pairwise replicates -m 0 -n manual –size factors 1 1 0.75
0.75) (18), using the two replicates of the respective pull-
down condition as foreground and the two replicates of
the corresponding control pull-down condition (specifi-
cally, IgG pull-downs for XL17-18 using cross-linked cells)
as background. Since library XL22 was not paired with a
control, its peaks were called using the control of library
XL21, which was generated using a UV-crosslinked cell-
line expressingGFP3xFHBH. For XF1-8 libraries, a Flp-In T-
REx 293 cell line with the parental tagging plasmid without
an insert was constructed and used for background deter-
mination afterUV-crosslinking (Supplementary Figure S2).
For SR- and FLASH libraries with transiently expressed
QKI proteins (Figures 4 and 5), a GFP3xFHBH cell line and a
GFP3xFHBH expression plasmid were used respectively after
UV-crosslinking. For the analysis shown in Figure 3D we
created two sets of peaks using a) crosslinked nucleotides ex-
tended by 5 nucleotides up- and downstream and b) whole
alignments of the corresponding reads.
Heatmaps showing pairwise Spearman correlations (Fig-
ure 4E and Supplementary Figure S6) and the prin-
cipal component analysis (Supplementary Figure S2B)
were created using deepTools (v3.1.1) (19) and are based
on crosslinking event counts of non-overlapping 200 nu-
cleotide genomic bins.
Bar plots showing overlap between U2AF2 data
(FLASH and eCLIP) and transcript features and motif
analysis of U2AF2 FLASH data in Supplementary Figure
S8 were generated by RCAS (20) using crosslinking sites
identified with PureCLIP (16).
Also see Supplementary Table S2 for mapping statistics
for the libraries reported in this study.
RESULTS
The s-oligo enables rapid RNA–protein interaction mapping
We designed a new adapter (the s-oligo) for CLIP-seq ex-
periments with the following considerations: (a) It should
be ligated to RNA molecules with a 3′-OH end, (b) it
should contain random nucleotides (also referred to as
UMI: Unique Molecular Identifier) that can be used to re-
move PCR duplicates, (c) it should contain unique, pre-
determined sequences for indexing and multiplexing, (d)
it should contain sequence elements that should minimize
and/or eliminate gel purifications and (e) it should contain
chemical groups that suppress various ligation and PCR ar-
tifacts. Several different flavors of this adapter design can be
used for different types of experimental requirements, how-
ever we will describe the use of the type depicted in Figure
1B.
The s-oligo is an RNA/DNA chimera, with a 5′-dangling
single-stranded RNA that is made up of 6 non-random
index ribonucleotides (XXXXX) that are sandwiched be-
tween 7 random ribonucleotides that constitute the Unique
Molecular Identifier (UMI, NNXXXXXXNNNNN).
Splitting the UMI into two and sandwiching the internal
index between them serves two purposes: to reduce ligation
bias, as the first two nucleotides ligated by the T4 RNA
ligase (or other suitable ligase) on the adapter side are
random, and to facilitate cluster identification in Illumina
sequencers (21). The single-stranded RNA part is followed
by a DNA duplex that is linked by a non-nucleic acid C18
spacer. Both the 5′- and the 3′-ends of the adapter are
phosphorylated for reasons described below.
Ligation of the s-oligo to RNA is typically carried out
by T4 RNA Ligase 1 (Figure 1D), which ligates the dan-
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get RNA. The phosphate group at the 3′-end blocks self-
ligation of the adapter to itself, which is essential to prevent
generating ‘empty insert’ amplicons at the end of the proto-
col. After ligation, the 3′-phosphate group is removed with
a phosphatase. The very 3′-end of the s-oligo base-pairs
with the DNA segment that immediately follows the dan-
gling RNA part (yellow nucleotides in Figure 1B), there-
fore this molecule is ready for reverse transcription (RT) im-
mediately after dephosphorylation since the duplex-DNA
part serves as a RT primer (purple nucleotides in Figure
1B). Reverse transcription is then carried out by adding an
RNA-dependent DNA polymerase and dNTPs to the lig-
ation products. After RT is completed, RNaseH is added
to the reaction. This step is generally carried out to remove
RNA and increase the efficiency of PCR (22). In FLASH,
we exploit the fact that RNaseH requires, and leaves, a 5′-
phosphate group as it degrades RNA/DNA hybrids pro-
cessively. By doing so, we not only remove all RNA but
also effectively phosphorylate the very first deoxyribonu-
cleotide moiety that follows the dangling ssRNA segment
(Figure 1D). This creates a cDNA molecule that has a 5′-
phosphate at its 5′-terminus and a 3′-OH at its 3′-terminus,
which can be circularized using CircLigase. After circular-
ization, cDNA is amplified directly by PCRwithout the lin-
earization of the cDNA or further purification (Figure 1B–
D).
Howandwhy does this cloning procedurewith the s-oligo
dramatically speed up CLIP protocols? There are several
reasons. One of the most persistent problems in ligation-
mediated cloning of RNA (which is the general path taken
by almost all CLIP protocols (3)) is the production of so-
called ‘adapter-dimers’, which in most cases can be thought
of as ‘zero-length inserts’. These are products of either self-
ligation of adapters or reverse-transcription primers which
can eventually become PCR templates. We undercut these
artifacts by blocking self-ligation by a 3′-phosphate group,
which we later remove for reverse transcription (Figure
1D). Additionally, since we do not use additional reverse-
transcription primers, the problems associated with using
excess RT primer also do not exist in our protocol. Finally,
we use a C18 spacer group, both to give flexibility to our
adapter so that smaller inserts are circularized properly,
and to function as a polymerase-block, enabling us to di-
rectly use circularization products for PCR. Electrophore-
sis of RNA-protein adducts on a polyacrylamide gel and
isolation of distinct regions that are thought to contain
RNAs that are bound to the protein-of-interest is a typ-
ical part of many CLIP protocols (3); however cutting a
membrane or a gel is an intrinsically imprecise process and
will inevitably be somewhat different for each protein, anti-
body, lane of gel and for each replicate; in addition to being
labor-intensive, time-consuming and inefficient procedure.
For this reason and as a result of the design choices detailed
above, we do not use gel purifications at any stage of the pro-
tocol, and thus, starting from cells on plates and ending up
with a dsDNA library ready for high-throughput sequenc-
ing, the protocol can be completed within ∼10 h. How-
ever, we split the protocol into two days for convenience and
to increase the efficiency of the cDNA circularization step
(Figure 1C).
Optimization of FLASH protocol with QKI
Flexibility of the FLASH protocol allows users to explore a
large number of parameters in order to find the best possi-
ble experimental setup for a given purpose. The Blueprint
depicted in Figure 1C, shows the general architecture of
FLASH experiments. The first important technical fork
in FLASH experiments is the choice of the purification
method to enrich for the protein-of-interest. One can ei-
ther use specific antibodies against a target (FLASHendo)
or use a stringent affinity-purification scheme to pull down
a tagged protein (FLASHtagged, see Figure 1C). We will de-
scribe the use of specific antibodies in the next section.How-
ever, since every antibody is unique in its biophysical prop-
erties, we optimized our method with tagged proteins first.
We used two cell lines: one expressing QKI-53xFHBH, a
nuclear isoform of QKI and another that expresses QKI-
63xFHBH, an isoform that has a significant cytoplasmic pool.
These two isoforms and their in vivo targets were charac-
terized in detail recently (6). We tested three forks in the
FLASH protocol using these two tagged isoforms of QKI
with defined binding behaviors (Figure 2A; Supplemen-
tary Figures S1 and S2A for the complete setup). First, we
tested the impact of the purification scheme on the abil-
ity of FLASH to precisely locate binding and the quality
of the final data, which is rarely, if at all, experimentally
tested in other CLIP protocols. For this purpose, we used
either single-step FLAG immunoprecipitation or polyhis-
tidine (HIS) pull-down followed by streptavidin (STREP)
purification. Second, we tested whether a FLASH proto-
col variation that does not have an RNA purification step
would be possible. For researchers accustomed to published
CLIP-seq protocols, this can be quite an unusual varia-
tion, in which the target RNA, crosslinked to the protein-
of-interest on beads, is directly reverse-transcribed by sim-
ply resuspending the beads with a reaction mix contain-
ing a reverse-transcriptase enzyme and dNTPs, bypassing
not only gel purifications and/or RNA isolation from ni-
trocellulose paper but also proteinase K treatment, phenol-
chloroform or Trizol extractions and/or column purifica-
tions. This is possible in FLASH due to the geometry of the
s-oligo, which comes with its reverse-transcription primer
covalently linked to it (Figure 1B). Finally, we tested two
different ways to phosphorylate the 5′-end of the cDNA
after reverse transcription, which is necessary for the cir-
cularization reaction that follows it. Here, we used either
base-catalyzed degradation of RNAwith 0.1 M sodium hy-
droxide (NaOH) and subsequent phosphorylation of the
5′-ends with T4 Polynucleotide kinase (PNK) and Adeno-
sine Triphosphate (ATP) or we simply added RNaseH to
our samples immediately after the reverse-transcription re-
action. RNaseH is generally used to remove RNA-DNA
hybrids after reverse transcription to improve PCR per-
formance, but due to the geometry of the s-oligo, it ends
up leaving a phosphate group at the 5′-end of the cDNA
molecule (Figure 1D). We processed a total of 48 sam-
ples distributed over 8 sequencing libraries for this exper-
iment alone (Figure 2A and Supplementary Figure S2A).
A PCA plot demonstrates that QKI libraries XF1-4 group
with each other and close to uvCLAP libraries that were
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cluster close together but further from uvCLAP libraries (6)
(Supplementary Figure S2B).
In summary, we observed that HIS-STREP purifications
(XF1-4, for RNA target distributions, see Supplementary
Figure S3) performed better than FLAG (XF4-8, for RNA
target distributions, see Supplementary Figure S4) purifica-
tions without any compromises on protein purity as judged
by silver-stained gels (see (6)). Second, we observed no sig-
nificant differences betweenRNaseH-mediated phosphory-
lation of cDNAends andT4PNKandATP-mediated phos-
phorylation of cDNA ends after hydrolysis of RNA with
0.1M NaOH (XF1 versus XF2, XF3 versus XF4, XF5 ver-
sus XF6 and XF7 versus XF8, Figure 2B–D). Finally, skip-
ping RNA purification and carrying out reverse transcrip-
tion on beads did have an interesting effect on the data.
As can be seen in Figure 2D, the libraries prepared with
proteinase K treatment and RNA-purification steps (XF1-
2 and XF5-6) the peak of RBD binding shows abrupt end
at a QKI motif (AYUAA), with a smaller tail following it,
presumably showing the cross-linking site and read-though
events, while on-beads reverse-transcribed libraries (XF3-
4 and XF7-8) do not show an abrupt end at QKI motif,
and rather show an accumulation of events mostly before
the motif and the tail is no longer seen. A plot that shows
the distribution of the QKI motif among cross-linked frag-
ments (Figure 2C) verifies these observations genome-wide,
in that the motif peak shifts ∼10 nucleotides to the left,
similar to the example shown in Figure 2D. Presumably,
this observation indicates that, without proteinase K treat-
ment and RNA isolation, the reverse transcriptase is un-
able to reach the crosslinking site due to steric hindrance,
and cannot travel beyond it, providing ‘RNA toeprints’ (23)
rather than cross-linking sites. When all is taken into ac-
count, we recommend the XF2 protocol to be the canonical
FLASHtagged protocol for most applications.
Comparison of FLASHtagged and FLASHendo protocols with
U2AF65
Using tagged proteins has many advantages in CLIP exper-
iments, especially when the tag or the tag combination al-
lows for stringent purifications that can efficiently eliminate
co-purifying proteins, as in FLASH (Supplementary Figure
S5 also see (6)). Such purity is virtually impossible to obtain
with protocols that use specific antibodies, even when cou-
pled to gel electrophoresis and nitrocellulose transfers, as
co-purifying proteins with similar molecular weight to the
protein-of-interest will co-migrate on the polyacrylamide
gel as well. Moreover, tagged proteins make it easy to study
derivatives of the protein of interest; be it deletions, point
mutations or domain swaps, together with matched nega-
tive controls. In addition, the timing and amount of tagged
protein can be modulated with inducible systems for ex-
pression or degradation of the protein of interest. When
endogenous expression is preferable over ectopic expres-
sion, tags can be inserted into the endogenous locus using
CRISPR-Cas9 with relative ease (24). However, not all pro-
teins tolerate affinity tags, and even with the most strin-
gent phenotypic tests claiming otherwise, affinity tags will
usually affect some aspects of the target protein. For ex-
ample, a tagged protein will definitely diffuse slower than
the native untagged protein, which may or may not affect
the function or RNA targets of the protein. Furthermore,
tagging target proteins may simply not be an option when
working with challenging samples such as tissue biopsies or
post-mortem brain samples (25).We thus generated a stable
cell line expressing U2AF653xFHBH, generated sequencing
libraries with the FLASHtagged protocol, and compared the
results to a FLASHendo protocol, where we used a mono-
clonal antibody against U2AF65 (MC3) which is frequently
used in CLIP experiments (26). The FLASHendo protocol is
almost identical to the FLASHtagged protocol, the only dif-
ferences being the use of protein G-coupled paramagnetic
beads, a single-step purification using the specific antibody
and the skipping of stringent wash buffers that contain 0.5%
LiDS or 1% SDS to preserve antibody-antigen interactions
(Figure 3A). As with FLASHtagged protocols, no gels were
used in this protocol variant. With all libraries (Figure 3B)
(both endo and tagged) we could recover the known bind-
ing preference of U2AF65, both in terms of sequence iden-
tity (polypyrimidine tracts) and the positioning of its targets
(upstream of exon-intron boundaries) (Figure 3C). The re-
covered motifs were sharply centered around cross-linking
sites in both endo and tagged libraries, pointing to single-
nucleotide resolution at binding sites (Figure 3D). As ex-
pected, the FLASHendo libraries contained higher coverage
on exonic sequences compared to FLASHtagged libraries,
possibly due to the inability to wash away some of the bind-
ing partners such as U2AF35 or SR proteins due to reduced
stringency of washing conditions, a compromise made to
preserve antibody-antigen interactions (also see Supple-
mentary Figures S7 and S8 for RNA target distributions).
Interestingly, a similar shoulder of exonic enrichment is
also observed in libraries generated using eCLIP, a proto-
col which uses a polyclonal antibody against U2AF65, and
goes through both PAA-electrophoresis, transfer to nitro-
cellulose paper and isolation of protein-RNA adducts from
nitrocellulose. Finally, both FLASHtagged and FLASHendo
profiles agree well with published eCLIP profiles both at
canonical and non-canonical U2AF65 binding sites (Figure
3E) (4). In summary, FLASHendo protocol produces high-
quality data when used with U2AF65 monoclonal antibod-
ies and can be completed within 1.5 days. Other antibodies
should be tested on a case-by-case basis, andwhere possible,
should be compared to or supplemented with FLASHtagged
data.
Profiling ten human SR proteins with FLASH
SR proteins are an important group of RNA-binding pro-
teins that are involved in splicing and export of mRNAs in
all metazoans (27). They typically contain RRMs (RNA
recognition motif) as RNA-binding domains and a repet-
itive region composed of serines and arginines, in which
serine phosphorylation can affect their localization and/or
modulate their RNA-binding properties. A recent study
has generated iCLIP profiles of seven SR proteins in mice
(SRSF1-7) using GFP-tagged transgenes (28). We decided
to generate profiles for nine human SR proteins (SRSF1-
7, SRSF9 and SRSF11) together with a point mutant of
SRSF2 that is clinically important (SRSF2P95H) (29) as a
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pressing 3xFLAG-HBH SR proteins (Figure 4C) and fol-
lowed the FLASHtagged protocol to generate sequencing li-
braries (Figure 4D). As expected, SR proteins showed ex-
onic binding (Supplementary Figures S10 and S11) with a
variety of sequence motifs summarized in Figure 4F. In-
terestingly, SRSF2P95H bound a motif similar to SRSF2,
but with a cytosine replacing a guanine at the center of the
motif (Figure 4F), which is similar to a recently published
study which compared SRSF2 and SRSF2P95H usingHITS-
CLIP (30). This change is also visible in the correlation plot
(Figure 4E), where SRSF2P95H moves closer to SRSF7 and
SRSF3, both of which have a central cytosine in their recog-
nitionmotif determined by our FLASHdata.UsingGraph-
Prot (17), we also found that SR protein motifs are gener-
ally found in unstructured regions of RNA, with the excep-
tion of SRSF2 and its mutant SRSF2P95H, which are pre-
dicted to bind sequences that may form structures (Figure
4F, right).
FLASH enables rapid in vivo RNA-profiling upon transient
expression of RBPs
In order to be able to carry out a FLASHtagged protocol, it
is necessary to either generate a cell line that expresses the
protein-of-interest in an inducible manner, or the endoge-
nous locus of the target should be modified so that the pro-
tein is expressed with the affinity tag necessary for FLASH
experiments. These protocols are generally straightforward,
but since the FLASH experiment itself takes only 1.5 days,
generating these cell lines now becomes the bottleneck in
high-throughput experiments. We thus attempted FLASH
experiments on cells that are transiently transfected with
plasmids encoding RNA-binding proteins (Figure 5). Once
again, we used the QKI proteins as a reference, since we
have a good understanding of their target sequence and tar-
get distribution, and transfected QKI-53xFLAG-HBH, QKI-
63xFLAG-HBH and GFP3xFLAG-HBH expression plasmids into
Flp-In T-REx 293 cells. We transfected cells in a 6-well
format, and used one well (∼1 million cells) as a replicate
for each sample. Twenty-four hours post-transfection, cells
were lysed and processed using the FLASH protocol opti-
mized for tagged proteins (Figures 2A and 5A), ending with
a sequence library similar to other FLASH libraries (Figure
5B). Both the duplications levels (avg. reads per event 5.38–
5.73) and signal-to-noise ratios (6.71–6.83) were between li-
braries XF5-8 and XF1-4, which appear to be noisier than
ideal (Supplementary Table S2). Nevertheless, it was possi-
ble to reproducibly recover the QKI motif with the QKI-6
sample (Figure 5C), and to recapitulate the in vivo binding
pattern of both QKI-5 and QKI-6 (Figure 5D).
DISCUSSION
FLASH solves several important challenges that are intrin-
sic to many CLIP-seq protocols and opens the way to solve
other application-specific problems through rapid iteration
cycles. This means that the experimenter can test, rather
than assume, the effect of different parameters on the out-
come through pilot experiments. For instance, instead of
choosing one RNase concentration, a user can test a dozen
concentrations and pool all samples for sequencing after
ligation of the s-oligo. The experimenter can test the effect
of using different types of RNases, reverse-transcriptases,
RNA ligases, or any other enzyme used in the protocol. The
s-oligo can also be introduced into other CLIP-seq proto-
cols in order to shorten the protocol by several days. Fi-
nally, since all of the purifications described in the proto-
col can also be carried out using paramagnetic bead-based
purification strategies, FLASH has the unique potential to
be completely automated using a liquid-handling system.
This will enable truly high-throughput CLIP experiments to
study and understand the role of hundreds of RNA-binding
proteins and how they collectively regulate the fate of mR-
NAs as they emerge from RNA polymerase II.
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